Moyers-Montoya Edgar Daniel, Castañeda-Muñoz María Jazmín, Márquez-Olivas Daniel, Miranda-Ruvalcaba René, Martínez-Pérez Carlos Alberto, García-Casillas Perla E, Montejo-López Wilber, Nicolás-Vázquez María Inés, Escobedo-González René Gerardo
Instituto de Ingeniería y Tecnología, Universidad Autónoma de Ciudad Juárez, Ave. Del Charro 450 Norte, Ciudad Juárez 32310, Chihuahua, Mexico.
Centro Médico de Especialidades, Av. De las Américas #201 Nte. Col. Margaritas, Ciudad Juárez 32300, Chihuahua, Mexico.
Pharmaceuticals (Basel). 2024 Nov 26;17(12):1595. doi: 10.3390/ph17121595.
Breast cancer is a disease with a high mortality rate worldwide; consequently, urgent achievements are required to design new greener drugs, leaving natural products and their derivatives as good options. A constant antineoplastic effect has been observed when the phytoproduct contains an indole fragment. Therefore, the objective of this work was to carry out a thoughtful computational study to perform an appropriate evaluation of four novel molecules of the class of the 3-indolylquinones as phytodrug candidates for antineoplastic activity: thymoquinone (TQ), 2,6-dimethoxy-1,4-benzoquinone (DMQ), 2,3-dimethoxy-5-methyl-1,4-benzoquinone (DMMQ), and 2,5-dihydroxy-1,4-benzoquinone (DHQ). It is important to highlight that the obtained computational results of the target compounds were compared-correlated with the theoretical and experimental literature data previously reported of several indolylquinones: indolylperezone, indolylisoperezone, indolylmenadione, and indolylplumbagin (IE-IH, respectively). Results: The results revealed that the studied structures possibly presented antineoplastic activity, in addition to the fact that the reactivity parameters showed that two of the evaluated compounds have the option to present IC values lower than or similar to 25 mg/mL, activity like that of indolylisoperezone; moreover, they show molecular coupling to PARP-1. Finally, the prediction of the calculated physicochemical parameters coincides with the Lipinski and Veber rules, indicating that the adsorption, metabolism, and toxicity parameters are acceptable for the studied compounds, obtaining high drug score values. Finally, a comparison between the proposed molecules and others previously synthesized was appropriately performed, establishing that the synthesis of the studied compounds and the determination of their pharmacological properties in an experimental manner are of interest.
乳腺癌是一种在全球范围内死亡率很高的疾病;因此,迫切需要取得成果来设计新的更环保的药物,天然产物及其衍生物是很好的选择。当植物产物含有吲哚片段时,已观察到持续的抗肿瘤作用。因此,本研究的目的是进行一项深入的计算研究,以对四种新型3-吲哚基醌类分子作为抗肿瘤活性植物药物候选物进行适当评估:百里醌(TQ)、2,6-二甲氧基-1,4-苯醌(DMQ)、2,3-二甲氧基-5-甲基-1,4-苯醌(DMMQ)和2,5-二羟基-1,4-苯醌(DHQ)。需要强调的是,将目标化合物的计算结果与先前报道的几种吲哚基醌(分别为吲哚基过氧酮、吲哚基异过氧酮、吲哚基甲萘醌和吲哚基白花丹醌,即IE-IH)的理论和实验文献数据进行了比较和关联。结果:结果表明,所研究的结构可能具有抗肿瘤活性,此外,反应性参数表明,两种评估化合物有可能呈现低于或类似于25 mg/mL的IC值,具有与吲哚基异过氧酮类似的活性;而且,它们显示出与PARP-1的分子偶联。最后,计算得到的物理化学参数预测与Lipinski规则和Veber规则相符,表明所研究化合物的吸附、代谢和毒性参数是可接受的,获得了较高的药物评分值。最后,对所提出的分子与先前合成的其他分子进行了适当比较,确定以实验方式合成所研究的化合物并确定其药理性质是有意义的。